Benefits
Proposed Oxygen Delivery Support
Phosphate loading is theorized to raise red-blood-cell 2,3-DPG, which may shift the oxygen dissociation curve to support unloading of oxygen at the tissues during sustained aerobic exercise; human results are inconsistent.
May Support Peak Aerobic Capacity
Some cycling studies report small increases in VO2peak after several days of sodium phosphate loading, though the effect is not seen across all trials and appears form- and protocol-dependent.
Possible Time-Trial Benefit
Certain trials, especially those using tribasic sodium phosphate, have observed modest improvements in cycling time-trial output, while other well-controlled studies report no measurable performance change.
Phosphate As An Energy Substrate
Phosphate is a building block of ATP and phosphocreatine, the body's rapid energy currency, providing the biological rationale that has driven interest in phosphate loading among endurance athletes.
Buffering Contribution
Phosphate is one of the body's intracellular buffers, and supplemental phosphate has been proposed to add modestly to the capacity to resist exercise-induced changes in muscle pH, though this is not well established.
Mechanism of action
2,3-DPG Modulation
Supplemental phosphate is proposed to increase erythrocyte 2,3-diphosphoglycerate, a molecule that lowers hemoglobin's oxygen affinity and theoretically improves oxygen release to working muscle, though measured changes are inconsistent.
Phosphate As Energy Currency
Inorganic phosphate is incorporated into ATP and phosphocreatine, the high-energy phosphate stores that power muscle contraction, forming the conceptual basis for loading the body's phosphate pool before competition.
Intracellular pH Buffering
The phosphate buffer system helps stabilize intracellular pH; raising the phosphate pool has been suggested to support pH regulation during high-intensity work, but this contribution appears small relative to other buffers.
Sodium Is Incidental
The proposed ergogenic actions are attributed to the phosphate anion rather than the sodium counter-ion, so sodium phosphate is regarded as a phosphate delivery vehicle rather than a sodium buffer like citrate or bicarbonate.
Clinical trials
Crossover trial of tribasic sodium phosphate (50 mg/kg fat-free mass/day) loaded over 6 days, with repeated loading phases and VO2peak and time-trial testing
Trained male cyclists
Mean VO2peak was higher after loading, with further gains after a second loading phase, and some improvement in mean power output; time-trial gains did not all reach statistical significance, suggesting a possible additive aerobic effect.
Randomized, placebo-controlled trial of dibasic sodium phosphate (about 3.5 g/day for 4 days) before a 30 km cycling time trial
Trained cyclists
There was no evidence of an ergogenic benefit; phosphate and placebo produced no meaningful differences in performance, cardiovascular measures, or perceived exertion, reinforcing the equivocal and form-dependent nature of phosphate loading.